Literature DB >> 24442510

Pancreatic biopsies in type 1 diabetes: revisiting the myth of Pandora's box.

Mark A Atkinson1.   

Abstract

Over a century ago, inquisitive physicians made remarkable discoveries regarding pancreatic pathology in individuals with diabetes, including those who were likely afflicted with the type 1 (autoimmune) form of the disease. Those studies of post-mortem tissues noted unique anatomical changes in islet architecture as well as the presence of unusual cellular infiltrates. In the time since, investigations of pancreatic pathology have, with near uniformity, been restricted to analysis of organs obtained post-mortem. While clearly beneficial for addressing questions of the disorder's pathogenesis, concern exists regarding potential artefacts that might occur through analysis of tissues that have been recovered hours, often many hours, following death. Beyond this, studies of tissues obtained long after the diagnosis of type 1 diabetes may not disclose important physiological events occurring at onset or even earlier in the natural history of disease, before symptomatic hyperglycaemia. To this end, Krogvold and colleagues (in this issue of Diabetologia, doi: 10.1007/s00125-013-3155-y) undertook a potentially high-reward strategy involving pancreatic biopsy in living adults with recent-onset type 1 diabetes. Procedures were performed under informed consent, undertaken based on recent improvements in laparoscopic techniques, and carried out by individuals with considerable surgical experience. These efforts were terminated for ethical reasons following the occurrence of serious complications (including post-operative bleeding and pancreatic leakage). The experience lends itself to analogy with the Greek myth of Pandora's box where curiosity, in terms of a desire to see what resided inside a closed container, unleashed a series of ills on humans once the container was opened. In considering the moral of that myth, one must question whether the secrets of the pancreas in those living with type 1 diabetes should, for now, remain a mystery as the process of manipulating that organ for the purpose of curiosity does not occur without harm.

Entities:  

Mesh:

Year:  2014        PMID: 24442510      PMCID: PMC7322791          DOI: 10.1007/s00125-013-3159-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

1.  Collecting high-quality pancreatic tissue for experimental study from organ donors with signs of β-cell autoimmunity.

Authors:  Sisko Tauriainen; Kaija Salmela; Immo Rantala; Mikael Knip; Heikki Hyöty
Journal:  Diabetes Metab Res Rev       Date:  2010-10       Impact factor: 4.876

2.  Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study.

Authors:  Lars Krogvold; Bjørn Edwin; Trond Buanes; Johnny Ludvigsson; Olle Korsgren; Heikki Hyöty; Gun Frisk; Kristian F Hanssen; Knut Dahl-Jørgensen
Journal:  Diabetologia       Date:  2014-01-16       Impact factor: 10.122

3.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

Review 4.  Immunopathology of the human pancreas in type-I diabetes.

Authors:  Sarah J Richardson; Abby Willcox; Adrian J Bone; Noel G Morgan; Alan K Foulis
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

5.  Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity.

Authors:  A Imagawa; T Hanafusa; S Tamura; M Moriwaki; N Itoh; K Yamamoto; H Iwahashi; K Yamagata; M Waguri; T Nanmo; S Uno; H Nakajima; M Namba; S Kawata; J I Miyagawa; Y Matsuzawa
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

Review 6.  Imaging of β-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus.

Authors:  Valentina Di Gialleonardo; Erik F J de Vries; Marco Di Girolamo; Ana M Quintero; Rudi A J O Dierckx; Alberto Signore
Journal:  Endocr Rev       Date:  2012-08-13       Impact factor: 19.871

Review 7.  The pancreas in human type 1 diabetes: providing new answers to age-old questions.

Authors:  Mark A Atkinson; Roberto Gianani
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-08       Impact factor: 3.243

8.  Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.

Authors:  Ken T Coppieters; Francesco Dotta; Natalie Amirian; Peter D Campbell; Thomas W H Kay; Mark A Atkinson; Bart O Roep; Matthias G von Herrath
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

  8 in total
  17 in total

Review 1.  Metabolic abnormalities in the pathogenesis of type 1 diabetes.

Authors:  Shuyao Zhang; Clayton E Mathews
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

2.  Multiplexed In Situ Imaging Mass Cytometry Analysis of the Human Endocrine Pancreas and Immune System in Type 1 Diabetes.

Authors:  Yue J Wang; Daniel Traum; Jonathan Schug; Long Gao; Chengyang Liu; Mark A Atkinson; Alvin C Powers; Michael D Feldman; Ali Naji; Kyong-Mi Chang; Klaus H Kaestner
Journal:  Cell Metab       Date:  2019-01-31       Impact factor: 27.287

Review 3.  NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP).

Authors:  Klaus H Kaestner; Alvin C Powers; Ali Naji; Mark A Atkinson
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

4.  Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

Authors:  A L J Carr; D J Perry; A L Lynam; S Chamala; C S Flaxman; S A Sharp; L A Ferrat; A G Jones; M L Beery; L M Jacobsen; C H Wasserfall; M L Campbell-Thompson; I Kusmartseva; A Posgai; D A Schatz; M A Atkinson; T M Brusko; S J Richardson; B M Shields; R A Oram
Journal:  Diabet Med       Date:  2020-07-23       Impact factor: 4.359

5.  Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells.

Authors:  Daniel Neiman; David Gillis; Sheina Piyanzin; Daniel Cohen; Ori Fridlich; Joshua Moss; Aviad Zick; Tal Oron; Frida Sundberg; Gun Forsander; Oskar Skog; Olle Korsgren; Floris Levy-Khademi; Dan Arbel; Saar Hashavia; A M James Shapiro; Cate Speake; Carla Greenbaum; Jennifer Hosford; Amanda Posgai; Mark A Atkinson; Benjamin Glaser; Desmond A Schatz; Ruth Shemer; Yuval Dor
Journal:  JCI Insight       Date:  2020-07-23

Review 6.  Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".

Authors:  Sally C Kent; Stuart I Mannering; Aaron W Michels; Jenny Aurielle B Babon
Journal:  Curr Diab Rep       Date:  2017-09-02       Impact factor: 4.810

7.  Proteomic profiling of human islets collected from frozen pancreata using laser capture microdissection.

Authors:  Lina Zhang; Giacomo Lanzoni; Matteo Battarra; Luca Inverardi; Qibin Zhang
Journal:  J Proteomics       Date:  2016-09-13       Impact factor: 4.044

Review 8.  Pancreas Pathology During the Natural History of Type 1 Diabetes.

Authors:  Teresa Rodriguez-Calvo; Sarah J Richardson; Alberto Pugliese
Journal:  Curr Diab Rep       Date:  2018-10-06       Impact factor: 4.810

Review 9.  Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology.

Authors:  Kriti Joshi; Fergus Cameron; Swasti Tiwari; Stuart I Mannering; Andrew G Elefanty; Edouard G Stanley
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

10.  Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes.

Authors:  Howard R Seay; Erik Yusko; Stephanie J Rothweiler; Lin Zhang; Amanda L Posgai; Martha Campbell-Thompson; Marissa Vignali; Ryan O Emerson; John S Kaddis; Dave Ko; Maki Nakayama; Mia J Smith; John C Cambier; Alberto Pugliese; Mark A Atkinson; Harlan S Robins; Todd M Brusko
Journal:  JCI Insight       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.